<DOC>
	<DOC>NCT02235415</DOC>
	<brief_summary>Study of the efficacy and tolerance of Motens® (lacidipine) in patients with essential hypertension. To obtain information on the dosage used in practice and the tolerance at the start of treatment (12 weeks)</brief_summary>
	<brief_title>Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lacidipine</mesh_term>
	<criteria>Nonhospitalised patients of both sexes aged 18 years or more with essential hypertension requiring treatment according to the recommendations of the German League for Hypertension Patients who had the contraindications listed in the product information (the case report file contained a copy of the product information)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>